Le Lézard
Classified in: Health, Covid-19 virus
Subjects: SVY, CPG, CMG

The Québec Ombudsman's 2022-2023 Annual Report - News release 2 - Health services and social services: staff shortages, but really...


QUÉBEC CITY, Sept. 21, 2023 /CNW/ - Today, Québec Ombudsman Marc-André Dowd tabled his 2022-2023 Annual Report in the National Assembly.

Again, this year, numerous investigations by his institution have shown that glaring staff shortages throughout the public health and social services network are cited by authorities as the main reason for service cuts, reductions and disruptions.

"It's not enough to simply blame reduced services on staff shortages, especially for the most vulnerable groups. Even if it's clear that institutions need additional resources, they must do all they can to enable existing teams to maintain the most comprehensive services possible," said Mr. Dowd.


 

Are service users' needs the guiding principle?

The Québec Ombudsman's 2022-2023 Annual Report homes in on major failings in public health network organizations. Here are a few examples of situations that are cause for concern:

Exemplary dedication

"It would be unfair not to acknowledge the dedication of health and social services workers who often go beyond the call of duty under very difficult conditions," Marc-André Dowd emphasized.


 

A few figures

In 2022-2023, the Québec Ombudsman handled 2,233 grounds for complaints and reports about the health and social services network. 43.2% of these grounds were considered substantiated.

Main grounds for substantiated grounds for complaints and reports:

The Québec Ombudsman acts impartially and independently in ensuring that people's rights are respected in their dealings with public services. Its services are free and user-friendly.

For complete information about the Québec Ombudsman's 2022-2023 Annual Report, go to the Annual Reports section of our website.

SOURCE Protecteur du citoyen


These press releases may also interest you

at 08:30
Toitures Hogue's commitment to providing its employees with a structured, professional working environment that guarantees complete safety in the workplace, both on the job and on the job site, has just been awarded its renewed ISO 45001...

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

26 avr 2024
David J. Dykeman, co-chair of the Life Sciences & Medical...



News published on and distributed by: